For example, CTCF upregulation was linked to advanced or metastatic disease and poor prognosis in hepatocellular carcinoma and ovarian cancers (Zhang et al., 2017; Zhao et al., 2017). This evidence concerns the gene CTCF and metastatic neoplasm.